Saudi Arabia

A comprehensive guide to Saudi Arabia's SFDA MDS-G27 (2025) regulation on digital health. Understand the boundary between medical devices and wellness software.

Side-by-side comparison of investigational device rules: FDA 21 CFR Part 812 IDE, EU MDR Articles 62-82, Saudi SFDA MDS-REQ 2, and Canada's Investigational Testing Authorization.

Compare sponsor, importer, distributor and authorized-representative duties across EU MDR Articles 11-16, New Zealand WAND, Singapore HPA, Canada MDEL and Saudi SFDA MDS-REQ 9.

Compare how Saudi SFDA MDS-G23, Brazil ANVISA RDC 657/2022, Nigeria NAFDAC and Kenya PPB regulate Software as a Medical Device — definitions, risk classes, and filing routes.

Saudi SFDA 56,737-row device database: 1,608 ARs, top-20 concentration at 35.4%, and 13,717 devices expiring 2026-2027. Data-driven AR selection insights.

MENA medical device labeling guide covering Arabic language rules, UDI requirements, halal certification, and country expectations for Saudi Arabia, UAE, Egypt, Israel, Turkey, and Qatar.

Guide to digital health and AI medical device regulation in MENA, covering Saudi SFDA, UAE EDE, Turkey TITCK, Israel AMAR, SaMD, mHealth, DTx, and compliance strategy.

Compare IVD registration requirements across MENA, including Saudi SFDA, UAE EDE, Egypt EDA, Turkey TITCK, Israel AMAR, companion diagnostics, performance evidence, and point-of-care rules.

Compare MENA medical device clinical trial requirements, including Saudi SFDA, UAE, Egypt, Turkey, Israel, Qatar, authorization routes, evidence expectations, and multi-country trial planning.

Plan MENA medical device import, customs, and free zone strategy, including GCC tariffs, Saudi SABER and ZATCA, UAE EDE, Egypt EDA, Turkey TITCK, and duty optimization.

Analyze the 2026 MENA medical device market, including regional size, Saudi investment, GCC transactions, UAE and Egypt growth, digital health trends, and smart device demand.

Compare MENA medical device reimbursement systems, including Saudi CHI and NPHIES, UAE Daman, Turkey SGK, Israel Health Basket, Egypt UHIA, co-payments, and market access strategy.

Compare MENA post-market surveillance and vigilance rules for devices, including Saudi SFDA, UAE EDE, Turkey TITCK, Israel IRH, Egypt EDA, reporting timelines, PSURs, and shortage notices.

Guide to how Saudi Vision 2030 and UAE Operation 300bn affect medical device localization, procurement preferences, regulatory incentives, local content rules, and Gulf market entry.

See where CE marking supports device approvals across 25+ markets, including full reliance, abridged review, evidence acceptance, and remaining local steps.

Operational guide to transferring a Saudi SFDA MDMA authorized representative, covering process steps, 2026 fees, multi-AR rules, and escalation when the outgoing AR will not cooperate.

Benchmark medical device regulatory consulting rates by region and consultant tier, with cost drivers and budgeting guidance for registration projects in major markets.

Guide to Saudi Arabia's NUPCO medical device procurement, including framework tenders, SFDA registration, localization requirements, Wasfaty integration, and foreign manufacturer strategy.

How to register medical devices in Saudi Arabia, UAE, and the GCC — SFDA requirements, UAE regulatory framework, GCC harmonization, and practical market entry guidance.